DK1411967T3 - Blokerende peptid for inflammatorisk cellesekretion - Google Patents

Blokerende peptid for inflammatorisk cellesekretion

Info

Publication number
DK1411967T3
DK1411967T3 DK02756467.3T DK02756467T DK1411967T3 DK 1411967 T3 DK1411967 T3 DK 1411967T3 DK 02756467 T DK02756467 T DK 02756467T DK 1411967 T3 DK1411967 T3 DK 1411967T3
Authority
DK
Denmark
Prior art keywords
secretion
present
inflammatory cell
cell secretion
blocking peptide
Prior art date
Application number
DK02756467.3T
Other languages
English (en)
Inventor
Linda D Martin
Kenneth B Adler
Yuehua Li
Original Assignee
Univ North Carolina State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina State filed Critical Univ North Carolina State
Application granted granted Critical
Publication of DK1411967T3 publication Critical patent/DK1411967T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK02756467.3T 2001-06-26 2002-06-26 Blokerende peptid for inflammatorisk cellesekretion DK1411967T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30093301P 2001-06-26 2001-06-26
PCT/US2002/022270 WO2003000027A2 (en) 2001-06-26 2002-06-26 Blocking peptide for inflammatory cell secretion

Publications (1)

Publication Number Publication Date
DK1411967T3 true DK1411967T3 (da) 2011-11-28

Family

ID=23161217

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02756467.3T DK1411967T3 (da) 2001-06-26 2002-06-26 Blokerende peptid for inflammatorisk cellesekretion

Country Status (11)

Country Link
US (2) US20030013652A1 (da)
EP (1) EP1411967B1 (da)
JP (1) JP4610891B2 (da)
AT (1) ATE519493T1 (da)
AU (1) AU2002322475B2 (da)
CA (1) CA2452123A1 (da)
DK (1) DK1411967T3 (da)
ES (1) ES2369760T3 (da)
HK (1) HK1065702A1 (da)
PT (1) PT1411967E (da)
WO (1) WO2003000027A2 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7544772B2 (en) 2001-06-26 2009-06-09 Biomarck Pharmaceuticals, Ltd. Methods for regulating inflammatory mediators and peptides useful therein
US8501911B2 (en) 1999-02-24 2013-08-06 Biomarck Pharmaceuticals, Ltd Methods of reducing inflammation and mucus hypersecretion
EP2399599A3 (en) * 2005-01-20 2012-04-18 Biomarck Pharmaceuticals, Ltd. Mucin hypersecretion inhibitors and methods of use
JP5415767B2 (ja) 2005-11-10 2014-02-12 ボード オブ スーパーバイザーズ オブ ルイジアナ ステイト ユニバーシティー アンド アグリカルチュラル アンド メカニカル カレッジ 依存症及び他の精神神経疾患の治療のための組成物及び方法
SG173411A1 (en) 2006-07-26 2011-08-29 Biomarck Pharmaceuticals Ltd Methods for attenuating release of inflammatory mediators and peptides useful therein
KR20130135820A (ko) 2010-06-16 2013-12-11 엠베라 뉴로 테라퓨틱스 인코포레이티드 중독，정신 장애 및 신경퇴행성 질환 치료용 조성물 및 방법
HUE043971T2 (hu) 2013-04-05 2019-09-30 Biomarck Pharmaceuticals Ltd Egy fûtõrendszer mûködtetési eljárása, fûtõrendszer és felhasználásai
EP3554257B1 (en) 2016-12-15 2023-07-12 Société des Produits Nestlé S.A. Compositions and methods that modulate white blood cells or neutrophils in a companion animal
JP7048629B2 (ja) 2017-03-10 2022-04-05 エンベラ ニューロセラピューティクス，インコーポレイティド 医薬組成物およびその使用
AU2020298130A1 (en) * 2019-06-17 2022-01-20 Biomarck Pharmaceuticals Ltd. Peptides and methods of use thereof in treating uveitis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292498A (en) * 1991-06-19 1994-03-08 The University Of North Carolina At Chapel Hill Method of treating lung disease with uridine triphosphates
CA2102142A1 (en) * 1993-03-30 1994-10-01 Andrew J. Ghio Method of inhibiting oxidants using alkylaryl polyether alcohol polymers
WO2000050062A2 (en) * 1999-02-24 2000-08-31 North Carolina State University Methods and compositions for altering mucus secretion
CA2326970C (en) * 1999-12-03 2004-11-23 Pfizer Products Inc. Acetylene derivatives as anti-inflammatory/analgesic agents
ITTO20030856A1 (it) * 2003-10-31 2005-05-01 Skf Ab Attuatore lineare a vite a ricircolo di sfere con un dispositivo di sbloccaggio di sicurezza.

Also Published As

Publication number Publication date
PT1411967E (pt) 2011-09-30
CA2452123A1 (en) 2003-03-01
WO2003000027A2 (en) 2003-01-03
EP1411967B1 (en) 2011-08-10
ATE519493T1 (de) 2011-08-15
AU2002322475B2 (en) 2008-02-21
EP1411967A4 (en) 2004-12-15
JP2005519850A (ja) 2005-07-07
ES2369760T3 (es) 2011-12-05
EP1411967A2 (en) 2004-04-28
US20040180836A1 (en) 2004-09-16
WO2003000027A3 (en) 2003-05-08
JP4610891B2 (ja) 2011-01-12
US20030013652A1 (en) 2003-01-16
HK1065702A1 (en) 2005-03-04

Similar Documents

Publication Publication Date Title
SG170082A1 (en) Methods for regulating inflammatory mediators and peptides useful therein
MXPA02004666A (es) Gelatinas recombinantes.
DK1411967T3 (da) Blokerende peptid for inflammatorisk cellesekretion
DK1015622T3 (da) Praktisk sialylering in vitro af rekombinante glycoproteiner
DE69936351D1 (de) Glykosylierte proteine mit reduzierter allergenität
WO2007075438A3 (en) Polypeptides comprising unnatural amino acids, methods for their production and uses therefor
NZ515718A (en) Novel indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
MXPA04002562A (es) Combinacion de un pde-4 y nsaid.
ATE469911T1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
DK1511761T3 (da) Fremgangsmåde til fremstilling af cykliske peptider
IL150703A (en) Selective electrochemical reduction of halogenated 4 - aminopicolinic acids
BR0016632A (pt) Métodos e composições para a fabricação de lentes oftálmicas
NO20040604L (no) Trisykliske imidazolpyridiner
DE60214676D1 (de) Hochaffine antagonisten der elr-cxc chemokine
DE60209359D1 (de) Lösungsmittelverklebungsverfahren
ATE436068T1 (de) Informationsanzeigeeinheit
IL158278A0 (en) Chitosan and hydroxy carboxylic acid based porous and non-porous matrices
GB0411180D0 (en) Treatment of ballast water
SE9802507D0 (sv) Novel salts
WO2003082900A3 (en) Self-assembling-peptide-based structures and processes for controlling the self-assembly of such structures
MY142798A (en) Methods for preventing glyconoylation of proteins
TW200519206A (en) Methods for producing novel medaka and novel medaka
MXPA02010271A (es) Senal de trafico plegable senalizadora de incidencias provista de elementos luminosos.
DK1194158T3 (da) Anvendelse af UK 114-proteiner til hæmning af organtransplantatafstödning